Evidence map›Paper›PMID 36413074›Full record

ArticleG3 (Bethesda, Md.)2023

Impact of antibiotic perturbation on fecal viral communities in mice.

Jacqueline Moltzau Anderson, Tim Lachnit, Simone Lipinski, Maren Falk-Paulsen, Philip Rosenstiel

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jacqueline Moltzau AndersonInstitute of Clinical Molecular Biology, Christian-Albrechts University of Kiel, 24098 Kiel, Germany.ORCID 0000-0003-1398-5980
Tim LachnitZoological Institute, Christian-Albrechts University of Kiel, 24098 Kiel, Germany.ORCID 0000-0002-2880-5930
Simone LipinskiInstitute of Clinical Molecular Biology, Christian-Albrechts University of Kiel, 24098 Kiel, Germany.ORCID 0000-0002-9322-7372
Maren Falk-PaulsenInstitute of Clinical Molecular Biology, Christian-Albrechts University of Kiel, 24098 Kiel, Germany.
Philip RosenstielInstitute of Clinical Molecular Biology, Christian-Albrechts University of Kiel, 24098 Kiel, Germany.ORCID 0000-0002-9692-8828
Christian-Albrechts-Universität zu Kiel · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viruses and bacteriophages have a strong impact on intestinal barrier function and the composition and functional properties of commensal bacterial communities. Shifts of the fecal virome might be involved in human diseases, including inflammatory bowel disease (IBD). Loss-of-function variants in the nucleotide-binding oligomerization domain-containing protein 2 (NOD2) gene are associated with an increased risk of developing Crohn's disease, a subtype of human chronic IBD, where specific changes in fecal viral communities have also been described. To improve our understanding of the dynamics of the enteric virome, we longitudinally characterized the virome in fecal samples from wild-type C57BL/6J and NOD2 knock-out mice in response to an antibiotic perturbation. Sequencing of virus-like particles demonstrated both a high diversity and high interindividual variation of the murine fecal virome composed of eukaryotic viruses and bacteriophages. Antibiotics had a significant impact on the fecal murine virome. Viral community composition only partially recovered in the observation period (10 weeks after cessation of antibiotics) irrespective of genotype. However, compositional shifts in the virome and bacteriome were highly correlated, suggesting that the loss of specific phages may contribute to prolonged dysregulation of the bacterial community composition. We suggest that therapeutic interference with the fecal virome may represent a novel approach in microbiota-targeted therapies.

Indexed as

BacteriophagesInflammatory Bowel DiseasesVirusesAnimalsAnti-Bacterial AgentsBacteriaHumansMiceMice, Inbred C57BLAnti-Bacterial Agentsantibiotic perturbationintestinal bacteriophagesNOD2resiliencevirome

Identifiers

PMID36413074
PMCPMC9836353
OpenAlexW4309589255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.